Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement, unanimously ...

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp ... fueled by the strong performance of its implantable devices, biologics, accessories and unique surgical ...

Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations while engineers refine cooling techniques, improve battery resilience, and ...

Nevro Corp is a medical device company. Its key product is the ... It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a ...